Skip to main content
Clinical Trials/NCT02066922
NCT02066922CompletedNot Applicable

A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects

Alcon Research0 sites19 target enrollmentStarted: March 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
19
Primary Endpoint
Change in Average Central Corneal Curvature From Dispense at Week 1

Study Overview

Brief Summary

The purpose of this study is to compare the change from baseline in central corneal curvature at one week, between 2 silicone hydrogel lenses, in higher myopic subjects.

Detailed Description

Participants were expected to attend 4 office visits. Visit 1 was the Screening/Enrollment visit. At Visit 2 (Baseline Visit), participants were randomized and the study lenses were trial fit. At Visit 3 (Dispense Visit), participants received study lenses for approximately 1 week of wear. Visit 4 was the Exit visit. Expected duration of participation in the study was 3 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Sign Informed Consent document;
  • •Higher degree of myopia in both eyes, i.e. habitual contact lens power between -10.00 diopters (D) and -17.00D;
  • •Best corrected distance visual acuity greater than or equal to 20/30 in each eye (measured with either spectacle refraction or habitual contact lenses plus over refraction);
  • •Manifest astigmatism less than or equal to -1.00D;
  • •Soft contact lens wear in both eyes at least 5 days per week and at least 8 hours per day;
  • •Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • •Pregnant or lactating;
  • •Eye injury or surgery within twelve weeks immediately prior to enrollment;
  • •Any ocular condition that contraindicates contact lens wear;
  • •History of herpetic keratitis;
  • •Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including any use of topical ocular medications that would require instillation during contact lens wear, except for approved lubricating drops;
  • •Clinical significant dry eye not responding to treatment;
  • •Previous corneal or refractive surgery or irregular cornea;
  • •Requires reading glasses;
  • •Participation in a clinical trial (including contact lens or contact lens care product) within the previous 30 days;
  • •Wears habitual lenses in an extended wear modality (routinely sleeps in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment;
  • •Other protocol-defined exclusion criteria may apply.

Arms & Interventions

DAILIES TOTAL1

Experimental

Delefilcon A contact lens randomly assigned to one eye, with narafilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.

Intervention: Delefilcon A contact lens (Device)

DAILIES TOTAL1

Experimental

Delefilcon A contact lens randomly assigned to one eye, with narafilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.

Intervention: Narafilcon A contact lens (Device)

DAILIES TOTAL1

Experimental

Delefilcon A contact lens randomly assigned to one eye, with narafilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.

Intervention: Spectacles (Device)

TRUEYE

Active Comparator

Narafilcon A contact lens randomly assigned to one eye, with delefilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.

Intervention: Delefilcon A contact lens (Device)

TRUEYE

Active Comparator

Narafilcon A contact lens randomly assigned to one eye, with delefilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.

Intervention: Narafilcon A contact lens (Device)

TRUEYE

Active Comparator

Narafilcon A contact lens randomly assigned to one eye, with delefilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.

Intervention: Spectacles (Device)

Outcomes

Primary Outcomes

Change in Average Central Corneal Curvature From Dispense at Week 1

Time Frame: Dispense (Day 1 of lens wear), Week 1 (Day 8 of lens wear)

Corneal curvature (horizontal and vertical keratometry values on the same eye) was measured using a calibrated keratometer prior to study lens dispense (Day 1) and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Minus values in change-from-baseline indicate corneal flattening.

Secondary Outcomes

  • Number of Eyes With Change of >1.00 Diopter (D) in Spherical Equivalent of Subjective Refraction From Baseline at Week 1(Baseline, Week 1 (Day 8 of lens wear))

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials